VivoSim Labs, Inc. (VIVS) Cash Flow Statement
Where VIVS’s cash came from and went, FY2026
March 31, 2026 · U.S. dollars- Cash from operations
- −$10.8M
- Capital expenditures
- $0 0.0% of revenue
- Free cash flow
- −$10.8M −8,264.9% margin
- Returned to shareholders
- —
- Change in cash
- −$6.3M cash at year-end $5.2M
Cash from operations
−$10.8M
Investments (net)
+$94,000
Shares issued
+$4.8M
Other financing
−$363,000
Change in cash
−$6.3M
Drawn to scale: where the cash came from and how it was used. Hover for values.
VIVS operating cash flow, capex and free cash flow
Operating cash flowCapital expendituresFree cash flowFCF margin (right axis)
VIVS cash flow trends, FY2017–FY2026
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Operating cash flow | −$29.2MFY2017 | −$10.8MFY2026 | — | |
| Capital expenditures | $1.4MFY2017 | $0FY2026 | −100.0% | |
| Free cash flow | −$30.5MFY2017 | −$10.8MFY2026 | — | |
| Free cash flow margin | −722.0%FY2017 | −8,264.9%FY2026 | −7,542.9 pts | |
| Stock-based compensation | $7.4MFY2017 | $303,000FY2026 | −29.9%/yr | |
| Share buybacks (net) | $1,000FY2021 | $0FY2022 | −100.0% | |
| Capex / revenue | 32.0%FY2017 | 0.0%FY2026 | −32.0 pts |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
VIVS cash flow by activity
OperatingInvestingFinancingChange in cash
VIVS net income vs operating cash flow
Net incomeOperating cash flow
Operating cash flow above net income usually means earnings are backed by cash (depreciation and stock-based pay are non-cash expenses).
VIVS cash flow statement
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating activities | ||||||||||
| Net income | −$13.8M | −$2.5M | −$14.7M | −$17.3M | −$11.4M | −$16.8M | −$18.7M | −$26.6M | −$34.8M | −$38.4M |
| Depreciation & amortization | $215,000 | $266,000 | $280,000 | $293,000 | $142,000 | $41,000 | $1.1M | $980,000 | $1.3M | $1.1M |
| Stock-based compensation | $303,000 | $532,000 | $1.5M | $2.4M | $2.3M | $5.6M | $4.1M | $5.2M | $6.9M | $7.4M |
| Change in working capital | −$680,000 | $1.0M | −$2.0M | $2.3M | $597,000 | −$2.1M | −$998,000 | $24,000 | −$2.2M | $669,000 |
| Other non-cash items | $3.2M | −$8.8M | $252,000 | −$125,000 | $0 | $19,000 | −$424,000 | $63,000 | $21,000 | $52,000 |
| Cash from operating activities | −$10.8M | −$9.5M | −$14.7M | −$12.4M | −$8.5M | −$13.3M | −$14.9M | −$20.4M | −$28.9M | −$29.2M |
| Investing activities | ||||||||||
| Capital expenditures | $0 | −$13,000 | −$42,000 | −$396,000 | −$409,000 | −$405,000 | $0 | −$79,000 | −$296,000 | −$1.4M |
| Investments (net) | $94,000 | $9.0M | $816,000 | −$966,000 | −$409,000 | −$393,000 | — | — | — | — |
| Acquisitions & other investing | $0 | $13,000 | $42,000 | $396,000 | $409,000 | $405,000 | $747,000 | $3,000 | $4,000 | −$37,000 |
| Cash from investing activities | $94,000 | $9.0M | $816,000 | −$966,000 | −$409,000 | −$393,000 | $747,000 | −$76,000 | −$292,000 | −$1.4M |
| Financing activities | ||||||||||
| Share repurchases & issuance (net) | — | — | — | — | $0 | −$1,000 | — | — | — | — |
| Shares issued | $4.8M | $8.8M | $1.4M | $0 | $251,000 | $23.8M | $0 | $0 | $0 | $0 |
| Other financing | −$363,000 | $0 | $0 | $0 | −$46,000 | $38,000 | $4.9M | $13.2M | $10.1M | $31.2M |
| Cash from financing activities | $4.4M | $8.8M | $1.4M | $0 | $205,000 | $23.8M | $4.9M | $13.2M | $10.1M | $31.2M |
| Summary | ||||||||||
| Net change in cash | −$6.3M | $8.4M | −$12.4M | −$13.4M | −$8.7M | $10.1M | −$9.2M | −$7.3M | −$19.0M | $660,000 |
| Cash at end of period | $5.2M | $11.5M | $3.0M | $15.4M | $28.8M | $37.5M | $27.4M | $36.6M | $43.9M | $62.8M |
| Free cash flow | −$10.8M | −$9.5M | −$14.7M | −$12.8M | −$8.9M | −$13.7M | −$14.9M | −$20.5M | −$29.2M | −$30.5M |
| Free cash flow margin | −8,264.9% | −6,579.2% | −13,481.7% | −3,460.5% | −590.8% | — | −677.7% | −661.7% | −633.3% | −722.0% |
| Capex / revenue | 0.0% | 9.0% | 38.5% | 107.0% | 27.3% | — | 0.0% | 2.6% | 6.4% | 32.0% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating activities | ||||||||||||
| Net income | −$1.3M | −$5.8M | −$2.7M | −$2.5M | −$2.8M | $6.9M | −$3.4M | −$2.5M | −$3.3M | −$3.0M | −$3.6M | −$4.0M |
| Depreciation & amortization | $40,000 | $43,000 | $52,000 | $59,000 | $61,000 | $61,000 | $67,000 | $68,000 | $70,000 | $71,000 | $71,000 | $71,000 |
| Stock-based compensation | $91,000 | $86,000 | $67,000 | $72,000 | $78,000 | $91,000 | $130,000 | $155,000 | $156,000 | $201,000 | $157,000 | $675,000 |
| Change in working capital | −$724,000 | $535,000 | $188,000 | −$74,000 | −$1.3M | $530,000 | $706,000 | −$572,000 | $52,000 | $116,000 | −$121,000 | $142,000 |
| Other non-cash items | −$1.3M | $2.9M | $113,000 | $110,000 | $108,000 | −$9.6M | $743,000 | $256,000 | $83,000 | −$14,000 | −$25,000 | −$43,000 |
| Cash from operating activities | −$3.2M | −$2.2M | −$2.3M | −$2.4M | −$3.9M | −$2.0M | −$1.8M | −$2.6M | −$3.0M | −$2.7M | −$3.5M | −$3.1M |
| Investing activities | ||||||||||||
| Capital expenditures | −$23,000 | $0 | $0 | $0 | $0 | $0 | $0 | −$13,000 | $0 | $0 | $0 | −$27,000 |
| Investments (net) | — | $94,000 | $0 | $0 | $0 | $9.0M | $4,000 | $13,000 | $20,000 | $13,000 | $27,000 | — |
| Acquisitions & other investing | $0 | — | — | — | — | $0 | $0 | — | $0 | $0 | $0 | $39,000 |
| Cash from investing activities | −$23,000 | — | — | — | — | $9.0M | $4,000 | — | $20,000 | $13,000 | $27,000 | $12,000 |
| Financing activities | ||||||||||||
| Shares issued | $0 | $3.0M | $0 | $0 | $1.8M | $3.2M | $0 | $0 | $6.2M | $264,000 | $1.2M | $0 |
| Other financing | −$118,000 | −$117,000 | −$118,000 | $0 | −$128,000 | $0 | −$216,000 | −$371,000 | $0 | $0 | $0 | — |
| Cash from financing activities | −$118,000 | $2.9M | −$118,000 | $0 | $1.7M | $3.2M | −$216,000 | −$371,000 | $6.2M | $264,000 | $1.2M | — |
| Summary | ||||||||||||
| Net change in cash | −$3.4M | $736,000 | −$2.4M | −$2.4M | −$2.3M | $10.2M | −$2.0M | −$3.0M | $3.3M | −$2.4M | −$2.3M | −$3.1M |
| Cash at end of period | $1.8M | $5.2M | $4.4M | $6.8M | $9.2M | $11.5M | $1.3M | $3.3M | $6.3M | $3.0M | $5.4M | $7.8M |
| Free cash flow | −$3.2M | −$2.2M | −$2.3M | −$2.4M | −$3.9M | −$2.0M | −$1.8M | −$2.7M | −$3.0M | −$2.7M | −$3.5M | −$3.2M |
| Free cash flow margin | −17,977.8% | −5,595.0% | −8,734.6% | −8,492.9% | −10,648.6% | −3,990.2% | −7,504.2% | −8,850.0% | −7,648.7% | −9,210.3% | −70,440.0% | — |
| Capex / revenue | 127.8% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 43.3% | 0.0% | 0.0% | 0.0% | — |
| Operating cash flow / net income | — | — | — | — | — | −0.30 | — | — | — | — | — | — |
Negative numbers are cash paid out. Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported; data from EODHD.
VIVS cash generation
In fiscal 2026 (ended March 31, 2026), VivoSim Labs generated -$10.8 million of cash from operations and spent $0 on capital expenditures, leaving free cash flow of -$10.8 million, −8,264.9% of revenue. Cash and equivalents fell by $6.3 million over the year.
Related: VIVS income statement, VIVS balance sheet. See the VIVS stock overview for the latest quote and news.
VIVS cash flow FAQ
What is VivoSim Labs's free cash flow?
VivoSim Labs's free cash flow was -$10.8 million in fiscal 2026: -$10.8 million of operating cash flow minus $0 of capital expenditures It was -$9.5 million a year earlier..
How much cash does VivoSim Labs generate from operations?
VivoSim Labs generated -$10.8 million of cash from operating activities in fiscal 2026.